Global Neurology Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Neurostimulation, Interventional Neurology, Cerebrospinal Fluid (CSF) Management, and Neurosurgery Devices.

By End-User;

Hospitals, Specialty Clinics, and Ambulatory Surgical Centers.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn167577876 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Neurology Devices Market (USD Million), 2021 - 2031

In the year 2024, the Global Neurology Devices Market was valued at USD 13,122.60 million. The size of this market is expected to increase to USD 29,891.46 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 12.5%.

The global neurology devices market is a rapidly growing sector within the medical devices industry, driven by advancements in technology and an increasing prevalence of neurological disorders. Neurological conditions such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and multiple sclerosis are becoming more common due to factors like aging populations and lifestyle changes. This rising incidence necessitates improved diagnostic and therapeutic options, propelling the demand for various neurology devices, including neurostimulation devices, neuroimaging systems, and neurodiagnostic equipment. As healthcare providers and researchers seek innovative solutions to manage and treat neurological disorders, the market is expected to expand significantly in the coming years.

One of the key drivers of growth in the neurology devices market is the technological advancements that have enhanced the capabilities and effectiveness of these devices. Innovations in neurostimulation technologies, such as deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS), are offering new treatment options for patients with movement disorders and depression. Additionally, developments in neuroimaging techniques, including MRI and PET scans, provide more accurate and timely diagnoses, allowing for better patient management and treatment planning. The integration of artificial intelligence and machine learning into neurology devices is also facilitating improved data analysis and interpretation, enhancing the overall efficacy of neurological care.

North America currently dominates the global neurology devices market, primarily due to the presence of advanced healthcare infrastructure, high levels of healthcare spending, and a strong emphasis on research and development. The United States, in particular, is a hub for neurology device innovation, with numerous companies and research institutions focused on developing cutting-edge technologies. However, the Asia-Pacific region is expected to witness the fastest growth in the market, driven by increasing healthcare investments, rising awareness of neurological disorders, and a growing patient population. As healthcare systems in emerging economies continue to develop and expand access to neurological care, the global neurology devices market is poised for substantial growth and diversification in the years to come.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By End-User
    3. Market Snapshot, By Region
  4. Global Neurology Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Prevalence of Neurological Disorders
        2. Advancements in Technology
        3. Growing Healthcare Expenditure
        4. Rising Awareness and Screening Programs
      2. Restraints
        1. High Cost of Neurology Devices
        2. Stringent Regulatory Framework
        3. Shortage of Trained Professionals
        4. Concerns Over Data Privacy
      3. Opportunities
        1. Emerging Markets
        2. Telemedicine Integration
        3. AI and Machine Learning Applications
        4. Innovations in Wearable Devices
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Neurology Devices Market, By Product, 2021 - 2031 (USD Million)
      1. Neurostimulation
      2. Interventional Neurology
      3. Cerebrospinal Fluid (CSF) Management
      4. and Neurosurgery Devices
    2. Global Neurology Devices Market, By End-User, 2021 - 2031 (USD Million)
      1. Hospitals

      2. Specialty Clinics

      3. Ambulatory Surgical Centers

    3. Global Neurology Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America

        1. United States

        2. Canada

      2. Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Nordic

        7. Benelux

        8. Rest of Europe

      3. Asia Pacific

        1. Japan

        2. China

        3. India

        4. Australia & New Zealand

        5. South Korea

        6. ASEAN (Association of South East Asian Countries)

        7. Rest of Asia Pacific

      4. Middle East & Africa

        1. GCC

        2. Israel

        3. South Africa

        4. Rest of Middle East & Africa

      5. Latin America

        1. Brazil

        2. Mexico

        3. Argentina

        4. Rest of Latin America

  6. Competitive Landscape
    1. Company Profiles
      1. B. Braun Melsungen AG
      2. Boston Scientific Corporation
      3. Covidien PLC
      4. Integra LifeSciences Holdings Corporation
      5. Johnson and Johnson
      6. Medtronic Inc
      7. St Jude Medical Inc
      8. Stryker Corporation
      9. WL Gore & Associates Inc
      10. Magstim Co Ltd
  7. Analyst Views
  8. Future Outlook of the Market